These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
376 related items for PubMed ID: 15919436
1. Repeated steroid pulse therapies in HCV-positive liver recipients: significant risk factor for HCV-related graft loss. Bahra M, Neumann UP, Jacob D, Langrehr JM, Neuhaus P. Transplant Proc; 2005 May; 37(4):1700-2. PubMed ID: 15919436 [Abstract] [Full Text] [Related]
2. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation. Rosen HR, Shackleton CR, Higa L, Gralnek IM, Farmer DA, McDiarmid SV, Holt C, Lewin KJ, Busuttil RW, Martin P. Am J Gastroenterol; 1997 Sep; 92(9):1453-7. PubMed ID: 9317061 [Abstract] [Full Text] [Related]
3. Long-term outcome of liver transplants for chronic hepatitis C: a 10-year follow-up. Neumann UP, Berg T, Bahra M, Puhl G, Guckelberger O, Langrehr JM, Neuhaus P. Transplantation; 2004 Jan 27; 77(2):226-31. PubMed ID: 14742986 [Abstract] [Full Text] [Related]
4. A novel immunosuppressive strategy combined with preemptive antiviral therapy improves the eighteen-month mortality in HCV recipients transplanted with aged livers. Urbani L, Mazzoni A, Colombatto P, Bindi L, Biancofiore G, Tascini C, Menichetti F, Brunetto MR, Scatena F, Filipponi F. Transplantation; 2008 Dec 27; 86(12):1666-71. PubMed ID: 19104402 [Abstract] [Full Text] [Related]
5. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center. Testillano M, Fernandez JR, Suarez MJ, Gastaca M, Bustamante J, Pijoan JI, Montejo M, Valdivieso A, Ruiz P, Gonzalez J, Ortiz de Urbina J. Transplant Proc; 2009 Apr 27; 41(3):1041-3. PubMed ID: 19376421 [Abstract] [Full Text] [Related]
6. Influence of immunosuppression and effect of hepatitis C virus on new onset of diabetes mellitus in liver transplant recipients. Sánchez-Pérez B, Aranda Narváez JM, Santoyo Santoyo J, Fernández-Aguilar JL, Suárez Muñoz MA, González-Sánchez AJ, Pérez Daga JA, Ramírez Plaza CP, Carrasco Campos J, Jiménez Mazure C, Becerra Ortíz R. Transplant Proc; 2008 Nov 27; 40(9):2994-6. PubMed ID: 19010171 [Abstract] [Full Text] [Related]
7. Outcome of recurrent hepatitis C virus after liver transplantation in a randomized trial of tacrolimus monotherapy versus triple therapy. Manousou P, Samonakis D, Cholongitas E, Patch D, O'Beirne J, Dhillon AP, Rolles K, McCormick A, Hayes P, Burroughs AK. Liver Transpl; 2009 Dec 27; 15(12):1783-91. PubMed ID: 19938143 [Abstract] [Full Text] [Related]
8. Hepatitis C virus therapy, hepatocyte drug metabolism, and risk for acute cellular rejection. Kugelmas M, Osgood MJ, Trotter JF, Bak T, Wachs M, Forman L, Kam I, Everson GT. Liver Transpl; 2003 Nov 27; 9(11):1159-65. PubMed ID: 14586876 [Abstract] [Full Text] [Related]
9. Significant improvement in the outcome of HCV-infected transplant recipients by avoiding rapid steroid tapering and potent induction immunosuppression. Berenguer M, Aguilera V, Prieto M, San Juan F, Rayón JM, Benlloch S, Berenguer J. J Hepatol; 2006 Apr 27; 44(4):717-22. PubMed ID: 16487616 [Abstract] [Full Text] [Related]
10. Impact of immunosuppression and acute rejection on recurrence of hepatitis C: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Charlton M, Seaberg E. Liver Transpl Surg; 1999 Jul 27; 5(4 Suppl 1):S107-14. PubMed ID: 10431024 [Abstract] [Full Text] [Related]
11. Long-term follow-up after recurrence of primary biliary cirrhosis after liver transplantation in 100 patients. Jacob DA, Neumann UP, Bahra M, Klupp J, Puhl G, Neuhaus R, Langrehr JM. Clin Transplant; 2006 Jul 27; 20(2):211-20. PubMed ID: 16640529 [Abstract] [Full Text] [Related]
12. Liver transplantation for primary biliary cirrhosis: influence of primary immunosuppression on survival. Jacob DA, Neumann UP, Bahra M, Langrehr JM, Neuhaus P. Transplant Proc; 2005 May 27; 37(4):1691-2. PubMed ID: 15919432 [Abstract] [Full Text] [Related]
13. Rejection rates in a randomised trial of tacrolimus monotherapy versus triple therapy in liver transplant recipients with hepatitis C virus cirrhosis. Samonakis DN, Mela M, Quaglia A, Triantos CK, Thalheimer U, Leandro G, Pesci A, Raimondo ML, Dhillon AP, Rolles K, Davidson BR, Patch DW, Burroughs AK. Transpl Infect Dis; 2006 Mar 27; 8(1):3-12. PubMed ID: 16623815 [Abstract] [Full Text] [Related]
14. Treatment of steroid-resistant and recurrent acute cardiac transplant rejection with a short course of antibody therapy. Cantarovich M, Latter DA, Loertscher R. Clin Transplant; 1997 Aug 27; 11(4):316-21. PubMed ID: 9267721 [Abstract] [Full Text] [Related]
15. Efficacy and safety of induction therapy with rabbit antithymocyte globulins in liver transplantation for hepatitis C. Kamar N, Ribes D, Sandres-Saune K, Suc B, Barange K, Cointault O, Lavayssiere L, Durand D, Izopet J, Rostaing L. Transplant Proc; 2004 Nov 27; 36(9):2757-61. PubMed ID: 15621141 [Abstract] [Full Text] [Related]
16. Long-term outcomes in liver transplant patients with hepatic C infection receiving tacrolimus or cyclosporine. Villamil F, Levy G, Grazi GL, Mies S, Samuel D, Sanjuan F, Rossi M, Lake J, Munn S, Mühlbacher F, Leonardi L, Cillo U. Transplant Proc; 2006 Nov 27; 38(9):2964-7. PubMed ID: 17112875 [Abstract] [Full Text] [Related]
17. Promising early results with immunosuppression using rabbit anti-thymocyte globulin and steroids with delayed introduction of tacrolimus in adult liver transplant recipients. Tector AJ, Fridell JA, Mangus RS, Shah A, Milgrom M, Kwo P, Chalasani N, Yoo H, Rouch D, Liangpunsakul S, Herring S, Lumeng L. Liver Transpl; 2004 Mar 27; 10(3):404-7. PubMed ID: 15004768 [Abstract] [Full Text] [Related]
18. Successful withdrawal of prednisone after adult liver transplantation for autoimmune hepatitis. Trouillot TE, Shrestha R, Kam I, Wachs M, Everson GT. Liver Transpl Surg; 1999 Sep 27; 5(5):375-80. PubMed ID: 10477838 [Abstract] [Full Text] [Related]
19. The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis. Jain A, Mazariegos G, Pokharna R, Parizhskaya M, Kashyap R, Kosmach-Park B, Smith A, Fung JJ, Reyes J. Transplantation; 2003 Apr 15; 75(7):1020-5. PubMed ID: 12698091 [Abstract] [Full Text] [Related]
20. CMV hepatitis after liver transplantation: incidence, clinical course, and long-term follow-up. Seehofer D, Rayes N, Tullius SG, Schmidt CA, Neumann UP, Radke C, Settmacher U, Müller AR, Steinmüller T, Neuhaus P. Liver Transpl; 2002 Dec 15; 8(12):1138-46. PubMed ID: 12474153 [Abstract] [Full Text] [Related] Page: [Next] [New Search]